Screening Hybridomas for Anabolic Androgenic Steroids by Steroid Analog Antigen Microarray.

Hongwu Du,Guangyu Chen,Yongzhong Bian,Cenzan Xing,Xue Ding,Mengliang Zhu,Yiping Xun,Peng Chen,Yabin Zhou,Shaoxu Li
DOI: https://doi.org/10.4155/bio.15.67
IF: 2.695
2015-01-01
Bioanalysis
Abstract:BACKGROUND:Currently, dozens of anabolic androgenic steroids (AAS) are forbidden in the World Anti-Doping Agency Prohibited List, however, despite extensive investigation, there are still lots of AAS without corresponding monoclonal antibodies.RESULTS:A steroid analog antigen microarray made up of ten AAS was fabricated to screen the hybridoma and it was found an original unsuccessful clone turned out to be a candidate anti-boldenone antibody, without any cross-reactions with endogenous AAS or 44 different AAS standard reference materials tested.CONCLUSION:Our findings suggested that steroid analog antigen microarray could be a promising tool to screen and characterize new applications of antibodies for structure analogs, and this also exhibits the potential to fast identify effective epitopes of hybridomas in a single assay.
What problem does this paper attempt to address?